Electroacupuncture versus Moxibustion for Irritable Bowel Syndrome: A Randomized, Parallel-Controlled Trial

被引:10
|
作者
Shi, Yin [1 ]
Chen, Yue-Hua [2 ]
Yin, Xiao-Jun [1 ]
Wang, An-Qi [1 ]
Chen, Xing-Kui [3 ]
Lu, Jin-Hua [4 ]
Ji, Rong [1 ]
Bao, Chun-Hui [1 ]
Sun, Jie [1 ]
Zhao, Ji-Meng [1 ]
Wu, Huan-Gan [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Chinese & Western Med Integrated Hosp, Dept Clin Med, Shanghai 200437, Peoples R China
[2] Jinhua Municipal Cent Hosp, Dept Gastroenterol, Jinhua 321000, Peoples R China
[3] Jinhua Municipal Cent Hosp, Dept Acupuncture & Moxibust, Jinhua 321000, Peoples R China
[4] Jinhua Municipal Cent Hosp, Dept Med Imaging, Jinhua 321000, Peoples R China
关键词
VISUAL ANALOG SCALE; ACUPUNCTURE; MANAGEMENT; MECHANISMS; PREVALENCE; MOTILITY; RECEPTOR; THERAPY; PATHWAY;
D O I
10.1155/2015/361786
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. To compare the impacts of electroacupuncture (EA) and mild moxibustion (Mox) on patients with irritable bowel syndrome (IBS). Method. Eighty-two IBS patients were randomly allocated into EA group (n = 41) andMox group (n = 41) and received corresponding interventions for four weeks. Before and after the treatment, the Visual Analogue Scale for Irritable Bowel Syndrome (VAS-IBS) was used to evaluate the gastrointestinal symptoms and mental well-being; and the expression of serotonin (5-hydroxytryptamine, 5-HT), 5-HT3 receptor (5-HT3R), and 5-HT4 receptor (5-HT4R) in sigmoid mucosal tissue were detected. Results. Both EA and Mox can radically improve the total VAS-IBS score (P < 0.05), and EA was found to be more effective in ameliorating the symptom of constipation, while Mox was found to be more effective in ameliorating the symptom of diarrhoea. The abnormal expressions of 5-HT, 5-HT3R, and 5-HT4R in both groups were significantly improved after the treatments (all P < 0.05), and EA was superior to Mox in regulating the abnormally decreased 5-HT4R expression in IBS patients with constipation (.. < 0.05). Conclusion. Electroacupuncture and mild moxibustion were both effective in improving IBS symptoms and modulate abnormal expressions of 5-HT, 5-HT3R, and 5-HT4R in the colonic tissue.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Long-term effect of moxibustion on irritable bowel syndrome with diarrhea: a randomized clinical trial
    Bao, Chunhui
    Wu, Luyi
    Shi, Yin
    Shi, Zheng
    Jin, Xiaoming
    Shen, Jiacheng
    Li, Jing
    Hu, Zhihai
    Chen, Jianhua
    Zeng, Xiaoqing
    Zhang, Wei
    Ma, Zhe
    Weng, Zhijun
    Li, Jinmei
    Liu, Huirong
    Wu, Huangan
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [22] Efficacy and safety of different doses of moxibustion for irritable bowel syndrome: A randomised controlled pilot trial
    Kim, Taein
    Chung, Jiwon
    Bae, Seungwon
    Lee, Jaejun
    Kim, Jiyu
    Lee, Ju Ah
    Yoon, Sang Jun
    Go, Ho-Yeon
    Shin, Seon-Mi
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2018, 20 : 79 - 83
  • [23] Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
    Kaptchuk, Ted J.
    Friedlander, Elizabeth
    Kelley, John M.
    Sanchez, M. Norma
    Kokkotou, Efi
    Singer, Joyce P.
    Kowalczykowski, Magda
    Miller, Franklin G.
    Kirsch, Irving
    Lembo, Anthony J.
    PLOS ONE, 2010, 5 (12):
  • [24] Randomized controlled trial of Panax ginseng in patients with irritable bowel syndrome
    Heraldo A. C. Rocha
    Thiago V. Rocha
    Fernando J. F. Nóbrega
    Liana C. S. Morais
    Margareth F. F. M. Diniz
    Revista Brasileira de Farmacognosia, 2018, 28 : 218 - 222
  • [25] Effect of therapeutic guideline on irritable bowel syndrome: A randomized controlled trial
    Fukudo, Shin
    Hongo, Michio
    Shimosegawa, Tooru
    Sasaki, Daisuke
    Matsueda, Kei
    Harasawa, Shigeru
    Miura, Soichiro
    Mine, Tetsurya
    Kaneko, Hiroshi
    Arakawa, Tetsuo
    Haruma, Ken
    Torii, Akira
    Azuma, Takeshi
    Miwa, Hiroto
    Matsumoto, Takayuki
    Fukunaga, Mikihiko
    Handa, Masanori
    Kinoshita, Yoshikazu
    Okumura, Toshikatsu
    Miwa, Takeshi
    GASTROENTEROLOGY, 2008, 134 (04) : A419 - A419
  • [26] Randomized controlled trial of Panax ginseng in patients with irritable bowel syndrome
    Rocha, Heraldo A. C.
    Rocha, Thiago V.
    Nobrega, Fernando J. F.
    Morais, Liana C. S.
    Diniz, Margareth F. F. M.
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2018, 28 (02): : 218 - 222
  • [27] Effect of Acupuncture in Patients With Irritable Bowel Syndrome: A Randomized Controlled Trial
    Pei, Lixia
    Geng, Hao
    Guo, Jing
    Yang, Guohui
    Wang, Lin
    Shen, Rongrong
    Xia, Shuyu
    Ding, Min
    Feng, Hua
    Lu, Jin
    Li, Jing
    Liu, Lian
    Shu, Yanye
    Fang, Xiangdong
    Wu, Xiaoliang
    Wang, Xiaoxiao
    Weng, Shengjie
    Ju, Lu
    Chen, Xiao
    Shen, Hong
    Sun, Jianhua
    MAYO CLINIC PROCEEDINGS, 2020, 95 (08) : 1671 - 1683
  • [28] Irritable bowel syndrome with diarrhea (IBS-D) treated with moxibustion on heat-sensitive acupoints: a randomized controlled trial
    Hu Dan
    Kang Ming-fei
    Xiong Jun
    Deng Peng
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2012, 22 (02) : 1 - 5
  • [29] Low-FODMAP diet versus traditional dietary advice for diarrhea-predominant irritable bowel syndrome: A randomized, parallel-controlled trial with analysis of clinical and microbiological factors associated with patient outcome
    Zhang, Yawen
    Fox, Mark
    Dai, Ning
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32
  • [30] Effect of electroacupuncture at homotopic and heterotopic acupoints on abdominal pain in patients with irritable bowel syndrome: study protocol for a randomized controlled trial
    Yanhui Peng
    Hui You
    Xiaoman Chen
    Yanbing Chen
    Yiling Yang
    Jianpeng Huang
    Nenggui Xu
    Jianhua Liu
    Trials, 19